Nexpring Health
Nexpring Health is a global leader in Assisted Reproductive Technology (ART), providing consumables and equipment for in-vitro fertilization (IVF) procedures to hospitals, specialized clinics, and IVF laboratories across more than 115 countries.
Nexpring Health was established in 2024 via two primary transactions: the carve-out of Cook Medical's Reproductive Health portfolio and the take-private of Hamilton Thorne Ltd.
In January 2025, Nexpring Health signed the acquisition of Irvine Scientific's Reproductive Health assets, expanding its portfolio to vitrification and embryo culture media. The combined group offers a comprehensive range of high-quality and innovative ART products that improve the outcomes and accessibility of fertility treatments globally.
Visit Nexpring Health
